Nvidia May Actually Raise Its 70% Growth Guide In November

Nvidia retains a Strong Buy rating as supply constraints begin to ease, with major customers including SpaceX, Alphabet and Meta ramping AI infrastructure and demand described as well above Nvidia’s 70% growth outlook. Nvidia plans to double chip-testing capacity by 2027 and expand supply commitments, potentially supporting higher output and pricing power.

Analysis

The key market question is whether incremental testing capacity converts into shippable systems, not whether AI demand remains strong. If testing stops constraining output, the bottleneck can migrate to advanced packaging, HBM, networking, or data-center power; capacity gains would then benefit those upstream providers only if their own lead times and customer orders confirm it. Treat such supplier exposure as a watch item, not an automatic read-through.

For NVIDIA, more supply supports revenue only if customers can install and monetize the added compute. Large buyers also gain leverage as supply loosens, while Alphabet and Meta have incentives to route suitable workloads to internal accelerators. That creates a second-order risk: NVIDIA can ship more units yet face a less favorable mix or weaker pricing than the bullish framing implies. Capacity commitments amplify downside if customer deployment schedules slip.

Near term, sentiment may support the shares, but the 1–3 month test is reported shipment conversion and customer capex follow-through. Over 6–18 months, watch for custom-silicon substitution and whether supply expansion outruns power and facility readiness. The bullish thesis weakens if NVIDIA cuts forward guidance, customer capex plans are revised down, or added testing capacity fails to improve deliveries. No valuation or positioning data are provided, so avoid treating the rating as evidence that the shares are attractively priced.

Key Decisions for Investors

• Do not chase solely on the capacity narrative. Consider a staged long NVIDIA position only after company disclosures confirm that expanded testing capacity is translating into deliveries and forward guidance holds.
• For a relative-value expression, evaluate long NVIDIA versus short AMD only if subsequent order and guidance data show NVIDIA capturing incremental demand; size for the risk that custom accelerators or a broad semiconductor rally invalidate the spread.
• Track Alphabet and Meta capex commentary alongside evidence of internal-accelerator deployment. Downward revisions or faster workload substitution would challenge the assumption that customer infrastructure spending accrues mainly to NVIDIA.
• Keep packaging, HBM, networking, and data-center power names on a watchlist rather than buying a broad supplier basket. Require evidence of order growth and capacity availability before acting; the article does not establish which layer remains supply-constrained.